Chaloupka M, Herlemann A, Spek A, Gratzke C, Stief C. [Cytoreductive, radical prostatectomy in metastatic prostate cancer].
Urologe A 2017;
56:1430-1434. [PMID:
28983651 DOI:
10.1007/s00120-017-0505-2]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
The resection of the primary tumor in patients with metastatic prostate cancer is controversially debated. Retrospective clinical studies indicate survival benefits and prevention of secondary, locoregional complications; however, results of ongoing multicenter prospective studies are still lacking. This review highlights the rationale behind the cytoreductive prostatectomy and summarizes current clinical study results.
Collapse